Does LENVATINIB Cause Thyroid cancer? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Thyroid cancer have been filed in association with LENVATINIB (Lenvima). This represents 0.1% of all adverse event reports for LENVATINIB.
19
Reports of Thyroid cancer with LENVATINIB
0.1%
of all LENVATINIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Thyroid cancer From LENVATINIB?
Of the 19 reports, 2 (10.5%) resulted in death, 4 (21.1%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Thyroid cancer Listed in the Official Label?
Yes, Thyroid cancer is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Thyroid cancer?
RANITIDINE (6,038)
LEVOTHYROXINE (249)
ADALIMUMAB (241)
ETANERCEPT (152)
METHOTREXATE (125)
INTERFERON BETA-1A (101)
INFLIXIMAB (100)
SORAFENIB (100)
EXENATIDE (98)
PAZOPANIB (88)
Which LENVATINIB Alternatives Have Lower Thyroid cancer Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE